Skip to Content
Merck

GLYCOPRO

Glycoprotein Detection Kit

Sufficient for 10 mini-gels (10 × 10 cm) or 5 gels or membranes (16.5 × 19 cm)

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.32
UNSPSC Code:
12352200

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

usage

 kit sufficient for 10 mini-gels (10 × 10 cm),  kit sufficient for 5 gels or membranes (16.5 × 19 cm)

carbohydrate detection limit measuring range

25-100 ng/band

storage temp.

2-8°C

Quality Level

200

Application

The Glycoprotein Detection Kit is designed for the selective staining of glycoproteins on polyacrylamide gels and membranes using a modification of the Periodic Acid-Schiff (PAS) method. Staining of sugar moieties of glycoproteins yields magenta bands with a colorless background. The periodic acid/Schiff reagent stains vicinal diol groups found mainly on peripheral sugars and sialic acids and is used as a general glycoprotein stain.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1B - Eye Dam. 1 - Met. Corr. 1 - Ox. Liq. 1 - Resp. Sens. 1 - Skin Corr. 1A - STOT RE 1 Oral - STOT SE 1

target_organs

Eyes,Central nervous system, Thyroid

supp_hazards

EUH031

Storage Class

5.1A - Strongly oxidizing hazardous materials

flash_point_f

Not applicable

flash_point_c

Not applicable

wgk

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000327536
0000327536
SLCN9187
SLCN9185
SLCB3979

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Silvia Gómez-Sebastián et al.
BMC biotechnology, 12, 59-59 (2012-09-08)
Single-domain antibodies (sdAbs), also known as nanobodies or VHHs, are characterized by high stability and solubility, thus maintaining the affinity and therapeutic value provided by conventional antibodies. Given these properties, VHHs offer a novel alternative to classical antibody approaches. To
Feng Wang-Johanning et al.
Journal of the National Cancer Institute, 104(3), 189-210 (2012-01-17)
The envelope (env) protein of the human endogenous retrovirus type K (HERV-K) family is commonly expressed on the surface of breast cancer cells. We assessed whether HERV-K env is a potential target for antibody-based immunotherapy of breast cancer. We examined
Anthony G Tsolaki et al.
Molecular immunology, 54(3-4), 278-283 (2013-01-22)
In this study, we investigated the potential molecular and immunological differences of a recombinant fusion protein (Hybrid-1), comprising of the immunodominant antigens Ag85B and ESAT-6 from Mycobacterium tuberculosis, derived from two different expression systems, namely Mycobacterium smegmatis and Escherichia coli.
Sukanya Narasimhan et al.
Nature communications, 8(1), 184-184 (2017-08-05)
The Lyme disease agent, Borrelia burgdorferi, colonizes the gut of the tick Ixodes scapularis, which transmits the pathogen to vertebrate hosts including humans. Here we show that B. burgdorferi colonization increases the expression of several tick gut genes including pixr
Identification of glycoproteins on nitrocellulose membranes and gels.
D J Thornton et al.
Methods in molecular biology (Clifton, N.J.), 32, 119-128 (1994-01-01)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service